Article info

PDF

Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis

Authors

  1. Correspondence to Professor Murray B Urowitz , Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto Senior Scientist, Krembil Research Institute, Toronto Western Hospital, Toronto, ON M5T 2S8, Canada ; m.urowitz{at}utoronto.ca
View Full Text

Citation

Urowitz MB, Ohsfeldt RL, Wielage RC, et al
Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis

Publication history

  • Received July 3, 2018
  • Revised November 1, 2018
  • Accepted November 12, 2018
  • First published January 4, 2019.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.